Dechra Pharmaceuticals PLCDPH:LSE

720.00
1.00 / 0.14%
24.68k
56.01%
0.178
Latest price in GBXToday's changeShares traded1 year changeBeta
As of May 20 2013 15:15 BST.Data delayed by at least 15 minutes.

Summary

As of last trade Dechra Pharmaceuticals PLC (DPH:LSE) traded at 720.00, 9.03% below its 52-week high of 791.50, set on Apr 11, 2013.

52-week range
Today
458.75
May 21 2012
791.50
Apr 11 2013
Markit short selling activity
Low
Medium
High
Open712.50
Day high726.00
Day low711.50
Bid719.50
Offer720.50
Previous close719.00
Average volume133.84k
Shares outstanding87.12m
Free float82.87m
P/E (TTM)43.76
Market cap626.36m GBP
EPS (TTM)0.1643 GBP
Annual div (TTM)12.84 GBX
Annual div yield (TTM)1.79%
Div ex-dateMar 13 2013
Div pay-dateApr 09 2013
Last IC View
The last IC recommendation on Dechra Pharmaceuticals PLC shares was Hold at 692.00 on 26 Feb 2013
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Dechra Pharmaceuticals PLC+3.00%-3.87%+21.83%+56.01%+100.08%
FTSE 100 Index+1.69%+7.27%+20.30%+28.02%+8.91%
As of May 20 2013 15:15 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.